Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | PPARA | Q07869 | 4/20 | 0.57 |
| ▸ | PPARG | P37231 | 4/20 | 0.57 |
| ▸ | PPARD | Q03181 | 1/20 | 0.57 |
| ▸ | MMP8 | P22894 | 1/20 | 0.56 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.55 |
| ▸ | LTA4H | P09960 | 2/20 | 0.54 |
| ▸ | MAOB | P27338 | 2/20 | 0.54 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | LAP3 | P28838 | 1/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9493387 | 0.93 | L3MBTL1 (0.67) | LMNAL3MBTL1PPARAPPARGPPARD | |
| SCHEMBL27385612 | 0.92 | LMNA (0.65) | LMNAL3MBTL1PPARAPPARGPPARD | |
| SCHEMBL15707904 | 0.90 | LMNA (0.62) | LMNAL3MBTL1PPARAPPARGPPARD | |
| SCHEMBL6691879 | 0.89 | MAOB (0.62) | LMNAL3MBTL1PPARAPPARGPPARD | |
| SCHEMBL6312211 | 0.88 | LTA4H (0.65) | PPARAPPARGPPARDALOX5LTA4H | |
| SCHEMBL856250 | 0.87 | MMP8 (0.69) | LMNAL3MBTL1PPARGMMP8ALDH1A1 | |
| SCHEMBL27539789 | 0.86 | L3MBTL1 (0.61) | LMNAL3MBTL1PPARAPPARGPPARD | |
| SCHEMBL6713179 | 0.85 | LMNA (0.64) | LMNAL3MBTL1PPARAPPARGPPARD | |
| SCHEMBL7501342 | 0.85 | LMNA (0.64) | LMNAL3MBTL1PPARAPPARGPPARD | |
| SCHEMBL27461095 | 0.85 | LMNA (0.57) | LMNAL3MBTL1PPARAPPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9434670-B2 | Family of aryl, heteroaryl, O-aryl and O-heteroaryl carbasugars | TFCHEM (FR) | 2016-09-06 | — | — | US | disclosed |
| US-20140105839-A1 | FAMILY OF ARYL, HETEROARYL, O-ARYL AND O-HETEROARYL CARBASUGARS | TF-CHEM (FR) | 2014-04-17 | — | — | US | disclosed |
| EP-1660509-B1 | GLUCOPYRANOSYLOXY- PYRAZOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS, THE USE THEREOF AND PROCESSES FOR THE PREPARATION THEREOF | BOEHRINGER INGELHEIM INT (DE) | 2009-02-04 | — | — | EP | disclosed |
| US-7375090-B2 | Glucopyranosyloxy-pyrazoles, pharmaceutical compositions containing these compounds, the use thereof and processed for the preparation thereof | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-05-20 | — | — | US | disclosed |
| US-7375090-B2 | Glucopyranosyloxy-pyrazoles, pharmaceutical compositions containing these compounds, the use thereof and processed for the preparation thereof | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-05-20 | — | — | US | disclosed |
| US-7375090-B2 | Glucopyranosyloxy-pyrazoles, pharmaceutical compositions containing these compounds, the use thereof and processed for the preparation thereof | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140105839-A1 | FAMILY OF ARYL, HETEROARYL, O-ARYL AND O-HETEROARYL CARBASUGARS | SLC5A2, SLC5A1, SLC2A2 | LMNA 3870/4885L3MBTL1 1473/4885PPARA 1712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.